Evidence map›Paper›PMID 23928307›Full record

Trial reportThe Journal of biological chemistry2013

Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system.

Garima Agrahari, Zhong Liang, Jeffrey A Mayfield, Rashna D Balsara, Victoria A Ploplis, Francis J Castellino

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Group aMicrobiology spectrum · 2025
    Article
  2. Article
  3. Article
  4. Group AFrontiers in cardiovascular medicine · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Conformationally organized lysine isosteres inThe Journal of biological chemistry · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Garima AgrahariW. M. Keck Center for Transgene Research; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556.
Zhong LiangW. M. Keck Center for Transgene Research.
Jeffrey A MayfieldW. M. Keck Center for Transgene Research.
Rashna D BalsaraW. M. Keck Center for Transgene Research; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556.
Victoria A PloplisW. M. Keck Center for Transgene Research; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556.
Francis J CastellinoW. M. Keck Center for Transgene Research; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556. Electronic address: fcastell@nd.edu.
University of Notre Dame · USW. M. Keck Foundation · US

Funding

STRUCTURE-FUNCTION STUDIES ON PLASMINOGEN AND PLASMINR01HL013423 · NHLBI · UNIVERSITY OF NOTRE DAME · PI CASTELLINO, FRANCIS J, LEE, SHAUN · 1985 to 2021
$7.9M
STRUCTURE/FUNCTION STUDIES ON PLASMINOGEN AND PLASMINR37HL013423 · NHLBI · UNIVERSITY OF NOTRE DAME · PI CASTELLINO, FRANCIS J · 1990 to 1999
–
NHLBI NIH HHS HL013423NHLBI NIH HHS R01 HL013423NHLBI NIH HHS R37 HL013423
6 · The paper itself

Abstract

Group A Streptococcus pyogenes (GAS) strain AP53 is a primary isolate from a patient with necrotizing fasciitis. These AP53 cells contain an inactivating mutation in the sensor component of the cluster of virulence (cov) responder (R)/sensor (S) two-component gene regulatory system (covRS), which enhances the virulence of the primary strain, AP53/covR(+)S(-). However, specific mechanisms by which the covRS system regulates the survival of GAS in humans are incomplete. Here, we show a key role for covRS in the regulation of opsonophagocytosis of AP53 by human neutrophils. AP53/covR(+)S(-) cells displayed potent binding of host complement inhibitors of C3 convertase, viz. Factor H (FH) and C4-binding protein (C4BP), which concomitantly led to minimal C3b deposition on AP53 cells, further showing that these plasma protein inhibitors are active on GAS cells. This resulted in weak killing of the bacteria by human neutrophils and a corresponding high death rate of mice after injection of these cells. After targeted allelic alteration of covS(-) to wild-type covS (covS(+)), a dramatic loss of FH and C4BP binding to the AP53/covR(+)S(+) cells was observed. This resulted in elevated C3b deposition on AP53/covR(+)S(+) cells, a high level of opsonophagocytosis by human neutrophils, and a very low death rate of mice infected with AP53/covR(+)S(+). We show that covRS is a critical transcriptional regulator of genes directing AP53 killing by neutrophils and regulates the levels of the receptors for FH and C4BP, which we identify as the products of the fba and enn genes, respectively.

Indexed as

PhagocytosisAnimalsBacterial ProteinsCarrier ProteinsComplement C3bComplement C4b-Binding ProteinComplement Factor HFemaleFructose-Bisphosphate AldolaseHistidine KinaseHumansIntracellular Signaling Peptides and ProteinsMaleMiceNeutrophilsProtein BindingBacterial ProteinsC4BPA protein, humanCarrier ProteinsComplement C3bComplement C4b-Binding ProteinComplement Factor HCovS protein, Streptococcus pyogenesCsrR protein, Streptococcus pyogenesEnn protein, Streptococcus pyogenesFba protein, Streptococcus pyogenesFructose-Bisphosphate AldolaseHistidine KinaseIntracellular Signaling Peptides and ProteinsRepressor ProteinsVirulence FactorsBacteriaBacterial GeneticsBacterial TranscriptionGene RegulationGene TranscriptionStreptococcus pyogenesTranscription RegulationTranscription Target Genes

Identifiers

PMID23928307
PMCPMC3779743
OpenAlexW2059312712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.